BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 17082577)

  • 1. GATA-3 regulates the development and function of invariant NKT cells.
    Kim PJ; Pai SY; Brigl M; Besra GS; Gumperz J; Ho IC
    J Immunol; 2006 Nov; 177(10):6650-9. PubMed ID: 17082577
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A critical role of costimulation during intrathymic development of invariant NK T cells.
    Chung Y; Nurieva R; Esashi E; Wang YH; Zhou D; Gapin L; Dong C
    J Immunol; 2008 Feb; 180(4):2276-83. PubMed ID: 18250436
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A cell-type specific CD1d expression program modulates invariant NKT cell development and function.
    Zimmer MI; Colmone A; Felio K; Xu H; Ma A; Wang CR
    J Immunol; 2006 Feb; 176(3):1421-30. PubMed ID: 16424169
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enforced expression of GATA-3 in transgenic mice inhibits Th1 differentiation and induces the formation of a T1/ST2-expressing Th2-committed T cell compartment in vivo.
    Nawijn MC; Dingjan GM; Ferreira R; Lambrecht BN; Karis A; Grosveld F; Savelkoul H; Hendriks RW
    J Immunol; 2001 Jul; 167(2):724-32. PubMed ID: 11441076
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Control of NKT cell differentiation by tissue-specific microenvironments.
    Yang Y; Ueno A; Bao M; Wang Z; Im JS; Porcelli S; Yoon JW
    J Immunol; 2003 Dec; 171(11):5913-20. PubMed ID: 14634102
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NKT cells enhance CD4+ and CD8+ T cell responses to soluble antigen in vivo through direct interaction with dendritic cells.
    Hermans IF; Silk JD; Gileadi U; Salio M; Mathew B; Ritter G; Schmidt R; Harris AL; Old L; Cerundolo V
    J Immunol; 2003 Nov; 171(10):5140-7. PubMed ID: 14607913
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A subset of NKT cells that lacks the NK1.1 marker, expresses CD1d molecules, and autopresents the alpha-galactosylceramide antigen.
    Hameg A; Apostolou I; Leite-De-Moraes M; Gombert JM; Garcia C; Koezuka Y; Bach JF; Herbelin A
    J Immunol; 2000 Nov; 165(9):4917-26. PubMed ID: 11046017
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The adaptor molecule signaling lymphocytic activation molecule-associated protein (SAP) regulates IFN-gamma and IL-4 production in V alpha 14 transgenic NKT cells via effects on GATA-3 and T-bet expression.
    Cen O; Ueda A; Guzman L; Jain J; Bassiri H; Nichols KE; Stein PL
    J Immunol; 2009 Feb; 182(3):1370-8. PubMed ID: 19155483
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Granulocyte-macrophage colony-stimulating factor regulates effector differentiation of invariant natural killer T cells during thymic ontogeny.
    Bezbradica JS; Gordy LE; Stanic AK; Dragovic S; Hill T; Hawiger J; Unutmaz D; Van Kaer L; Joyce S
    Immunity; 2006 Sep; 25(3):487-97. PubMed ID: 16949316
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Tec kinases Itk and Rlk regulate NKT cell maturation, cytokine production, and survival.
    Felices M; Berg LJ
    J Immunol; 2008 Mar; 180(5):3007-18. PubMed ID: 18292523
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IL-18 enhances IL-4 production by ligand-activated NKT lymphocytes: a pro-Th2 effect of IL-18 exerted through NKT cells.
    Leite-De-Moraes MC; Hameg A; Pacilio M; Koezuka Y; Taniguchi M; Van Kaer L; Schneider E; Dy M; Herbelin A
    J Immunol; 2001 Jan; 166(2):945-51. PubMed ID: 11145671
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel mouse model for invariant NKT cell study.
    Wakao H; Kawamoto H; Sakata S; Inoue K; Ogura A; Wakao R; Oda A; Fujita H
    J Immunol; 2007 Sep; 179(6):3888-95. PubMed ID: 17785826
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BATF transgenic mice reveal a role for activator protein-1 in NKT cell development.
    Williams KL; Zullo AJ; Kaplan MH; Brutkiewicz RR; Deppmann CD; Vinson C; Taparowsky EJ
    J Immunol; 2003 Mar; 170(5):2417-26. PubMed ID: 12594265
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The SLAM-associated protein signaling pathway is required for development of CD4+ T cells selected by homotypic thymocyte interaction.
    Li W; Sofi MH; Rietdijk S; Wang N; Terhorst C; Chang CH
    Immunity; 2007 Nov; 27(5):763-74. PubMed ID: 18031696
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD4+ NKT cells, but not conventional CD4+ T cells, are required to generate efferent CD8+ T regulatory cells following antigen inoculation in an immune-privileged site.
    Nakamura T; Sonoda KH; Faunce DE; Gumperz J; Yamamura T; Miyake S; Stein-Streilein J
    J Immunol; 2003 Aug; 171(3):1266-71. PubMed ID: 12874214
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A thymic pathway of mouse natural killer cell development characterized by expression of GATA-3 and CD127.
    Vosshenrich CA; García-Ojeda ME; Samson-Villéger SI; Pasqualetto V; Enault L; Richard-Le Goff O; Corcuff E; Guy-Grand D; Rocha B; Cumano A; Rogge L; Ezine S; Di Santo JP
    Nat Immunol; 2006 Nov; 7(11):1217-24. PubMed ID: 17013389
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of Th2 differentiation and GATA-3 expression by BCL-6.
    Kusam S; Toney LM; Sato H; Dent AL
    J Immunol; 2003 Mar; 170(5):2435-41. PubMed ID: 12594267
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TCR-dependent translational control of GATA-3 enhances Th2 differentiation.
    Cook KD; Miller J
    J Immunol; 2010 Sep; 185(6):3209-16. PubMed ID: 20696860
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GATA-3 - not just for Th2 cells anymore.
    Ho IC; Pai SY
    Cell Mol Immunol; 2007 Feb; 4(1):15-29. PubMed ID: 17349208
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human natural killer T cells are heterogeneous in their capacity to reprogram their effector functions.
    Eger KA; Sundrud MS; Motsinger AA; Tseng M; Van Kaer L; Unutmaz D
    PLoS One; 2006 Dec; 1(1):e50. PubMed ID: 17183680
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.